Cannabis Science
Has US Federal Government Clearance that Changes the
Industry, Access to Federal Government Contracts, Supported
US Federal Governments Since 2009, Looks for New Federal
Policy to Properly Regulate Industry for Patients .
Cannabis Science, Inc. Announces New Website, New
Management Team Expansions, & Pushes to Complete Updated
Financial Reporting Requirements
Phase I Underway, Cannabis Science 1,000–Acre Elpasso Farms
Economic Development Plan in South Africa; Agriculture, Food
Security, Phytomedicines, with an Emphasis on
Micro-Nutrients, and Education
Cannabis Science President & CEO Mr. Raymond C. Dabney
Awarded The 2018 Harvard Global Health Catalyst Industry
Leader Award May 25-27th at Harvard Medical School, Boston,
MA
Cannabis Science Announces the Second Frontiers
Peer-Reviewed Publication of its Research Results on the Use
of Cannabinoids in the Treatment of Cancers
Reasons
to buy these shares
-
Legalize Weed - Once In Lifetime Opportunity
-
These shares have recently soared
from 1 cent to over 11 cents and consolidated.
-
We expect a rapid rise in price with a target
now placed at $0.15 cents.
-
The company's
dynamic management team has driven this successful
company to unexpected heights
-
The company rapidly expanding into Bio Med
-Transdermal Patch Released - COPD / Asthma
Treatment
-
Seeding 350 acres to begin - Fact
Sheet CBIS
SPECIAL REPORTS
Special Report On Medical Marijuana - Sales Expected To Soar
Past $5.2 Billion
All About Weed Banking
|